Prognostic performance of ceramide-based risk scores for cardiovascular events and mortality in patients with coronary artery disease and heart failure: a systematic review and dose-response meta-analysis
2026 systematic review and dose-response meta-analysis: the CERT2 ceramide-phospholipid risk score showed a significant graded (linear) association with major adverse cardiovascular events (RR ~1.09 per one-unit increase).
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
European Journal of Medical Research
Jan 2026
Structured Methods
- Study Design
- Meta-analysis
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (2026). Prognostic performance of ceramide-based risk scores for cardiovascular events and mortality in patients with coronary artery disease and heart failure: a systematic review and dose-response meta-analysis. European Journal of Medical Research. https://doi.org/10.1186/s40001-026-04470-1
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
